Strategy | Financing Transactions Private Placement / Financing Transactions Borealis Biosciences: The company raised $150 million of Series A venture funding from Novartis and Versant Ventures on August 22, 2024. The company is an operator of a discovery-stage...
Strategy | Financing Transactions Private Placement / Financing Transactions EliseAI: The company raised $75 million through a combination of debt and Series D venture funding in a deal led by Sapphire Ventures on August 14, 2024, putting the company’s pre-money...
Strategy | Financing Transactions Private Placement / Financing Transactions Terviva: The company raised $36.2 million of venture funding from undisclosed investors on August 13, 2024. The company is an operator of a food technology business intended to deliver...
Strategy | Financing Transactions Private Placement / Financing Transactions Caresyntax: The company raised $180 million of funding through a combination of debt and equity on August 15, 2024. $80 million of Series C venture funding was provided by Blackrock...
Strategy | Financing Transactions Private Placement / Financing Transactions FLYR: The company raised $295 million through a combination of Series D equity and debt funding on August 8, 2024, putting the company’s pre-money valuation at $900 million. The company...
